Comparing investigation of the curative effect by Goshajinkigan and Pregabalin for -Induced Peripheral Neuropathy
Not Applicable
Recruiting
- Conditions
- Paclitacel -induced peripheral neuropathy in the patients with gynecological malignancies
- Registration Number
- JPRN-UMIN000011332
- Lead Sponsor
- ihon University Itabashi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 44
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with severe complications (such as heart failure, renal failure, liver failure, blood disease) 2)Patients with neuropathy due to apparently other causes such as diabetes or cingulum 3)Patients with history of allergy in Pregabalin or Goshajinkigan 4)Patient with the neurological symptoms by brain metastasis or bone metastasis 5)Patients who have been administered Pregabalin or Goshajinkigan previously for peripheral neuropathy 6)Patients for whom completion of this study is deemed inappropriate for any reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method